T Nishino

1.8k total citations
50 papers, 1.4k citations indexed

About

T Nishino is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, T Nishino has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 29 papers in Molecular Biology and 25 papers in Molecular Medicine. Recurrent topics in T Nishino's work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (25 papers) and Cancer therapeutics and mechanisms (15 papers). T Nishino is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (25 papers) and Cancer therapeutics and mechanisms (15 papers). T Nishino collaborates with scholars based in Japan, United Kingdom and South Korea. T Nishino's co-authors include Naomasa Gotoh, Masako Otsuki, Nobuhisa Masuda, J. Okuda, Satoshi Ohya, Hajime Tsujimoto, Youhei Takeda, Mitsuaki Nishibuchi, Sujit Bhattacharya and Eriko Hayakawa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

T Nishino

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Nishino Japan 20 604 532 385 379 255 50 1.4k
Carmen M. Herrera United States 23 695 1.2× 667 1.3× 158 0.4× 380 1.0× 120 0.5× 42 1.8k
Mark C. Sulavik United States 22 594 1.0× 906 1.7× 210 0.5× 194 0.5× 123 0.5× 28 2.0k
H. E. Gilleland United States 25 475 0.8× 723 1.4× 162 0.4× 217 0.6× 183 0.7× 43 1.6k
Jessica V. Hankins United States 11 477 0.8× 541 1.0× 103 0.3× 349 0.9× 325 1.3× 11 1.3k
Xavier Vila‐Farrés Spain 20 525 0.9× 902 1.7× 325 0.8× 247 0.7× 59 0.2× 25 1.5k
Samuel Bellais France 25 1.0k 1.7× 773 1.5× 182 0.5× 660 1.7× 60 0.2× 33 2.0k
Brooke A. Napier United States 17 306 0.5× 650 1.2× 97 0.3× 160 0.4× 199 0.8× 23 1.2k
Susanne Lindquist Sweden 19 449 0.7× 441 0.8× 99 0.3× 173 0.5× 47 0.2× 31 1.3k
Xuan Wang‐Kan United Kingdom 7 518 0.9× 382 0.7× 145 0.4× 147 0.4× 50 0.2× 7 930
T Une Japan 16 234 0.4× 535 1.0× 414 1.1× 126 0.3× 131 0.5× 33 1.3k

Countries citing papers authored by T Nishino

Since Specialization
Citations

This map shows the geographic impact of T Nishino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Nishino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Nishino more than expected).

Fields of papers citing papers by T Nishino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Nishino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Nishino. The network helps show where T Nishino may publish in the future.

Co-authorship network of co-authors of T Nishino

This figure shows the co-authorship network connecting the top 25 collaborators of T Nishino. A scholar is included among the top collaborators of T Nishino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Nishino. T Nishino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eida, Sato, Motoki Fukuda, Ikuo Katayama, et al.. (2024). Metastatic Lymph Node Detection on Ultrasound Images Using YOLOv7 in Patients with Head and Neck Squamous Cell Carcinoma. Cancers. 16(2). 274–274. 9 indexed citations
2.
Nishino, T, et al.. (1999). [In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].. PubMed. 52(8). 541–53. 3 indexed citations
3.
Sakagawa, Eiko, et al.. (1998). In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem. Journal of Antimicrobial Chemotherapy. 42(4). 427–437. 14 indexed citations
4.
Nishino, T, et al.. (1996). The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens. Journal of Antimicrobial Chemotherapy. 38(5). 771–776. 6 indexed citations
5.
Tanaka, Masatoshi, Masako Otsuki, T Nishino, et al.. (1996). Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.. Sexually Transmitted Infections. 72(4). 295–297. 12 indexed citations
6.
Ito, Tatsuya, M Matsumoto, & T Nishino. (1995). Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci. Antimicrobial Agents and Chemotherapy. 39(7). 1522–1525. 21 indexed citations
7.
Ito, Tatsuya, Keisuke Kojima, Kyoko Koizumi, Hideki Nagano, & T Nishino. (1994). Inhibitory Activity on DNA Gyrase and Intracellular Accumulation of Quinolones: Structure-Activity Relationship of Q-35 Analogs.. Biological and Pharmaceutical Bulletin. 17(7). 927–930. 9 indexed citations
8.
Otsuki, Masako, et al.. (1992). In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum. Antimicrobial Agents and Chemotherapy. 36(9). 1894–1901. 12 indexed citations
9.
Tanaka, Márcia Hiromi, Masako Otsuki, & T Nishino. (1992). In vitro and in vivo activities of DQ-2556 and its mode of action. Antimicrobial Agents and Chemotherapy. 36(12). 2595–2601. 6 indexed citations
10.
Kawai, Yosuke, et al.. (1992). In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.. PubMed. 18(2). 37–46. 14 indexed citations
11.
Nishino, T, et al.. (1991). In vitro and in vivo antibacterial activities of sparfloxacin, a new quinolone. Chemotherapy. 39. 59–77. 4 indexed citations
12.
Nishino, T, et al.. (1991). Adherence of Serratia marcescens in the pathogenesis of urinary tract infections in diabetic mice. Journal of Medical Microbiology. 35(2). 93–97. 12 indexed citations
13.
Okuda, J., Shuichiro Okamoto, Masahiro Takahata, & T Nishino. (1991). Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 35(11). 2288–2293. 24 indexed citations
14.
Tomii, Yoshifumi, Kiyoshi Kimura, Jiro Segawa, et al.. (1991). In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrobial Agents and Chemotherapy. 35(12). 2496–2499. 31 indexed citations
15.
Tanaka, M, Kenichi Sato, Yasuharu Kimura, et al.. (1991). Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 35(7). 1489–1491. 39 indexed citations
16.
Ikeda, Yoshito, et al.. (1990). Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice. Antimicrobial Agents and Chemotherapy. 34(1). 94–97. 11 indexed citations
17.
Gotoh, Naomasa, H Wakebe, Eisaku Yoshihara, Taiji Nakae, & T Nishino. (1989). Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. Journal of Bacteriology. 171(2). 983–990. 72 indexed citations
18.
Nishino, T, et al.. (1989). In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.. PubMed. 15(2). 53–8. 1 indexed citations
19.
Fukunaga, Rikiro, Kazuko Akashi, N Shimada, et al.. (1989). An ATP-driven Cl− Pump in the Brain. Journal of Biological Chemistry. 264(29). 17416–17421. 61 indexed citations
20.
Takahata, Masahiro & T Nishino. (1988). DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity. Antimicrobial Agents and Chemotherapy. 32(8). 1192–1195. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen M. Herrera Breakdown of academic impact, for papers by Mark C. Sulavik Breakdown of academic impact, for papers by H. E. Gilleland Breakdown of academic impact, for papers by Jessica V. Hankins Breakdown of academic impact, for papers by Xavier Vila‐Farrés Breakdown of academic impact, for papers by Samuel Bellais Breakdown of academic impact, for papers by Brooke A. Napier Breakdown of academic impact, for papers by Susanne Lindquist Breakdown of academic impact, for papers by Xuan Wang‐Kan Breakdown of academic impact, for papers by T Une
Rankless by CCL
2026